These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31060386)

  • 1. The effect of serotonin reuptake inhibitors on the vaginal epithelium in postmenopausal women.
    Shea AK; Meschino D; Wolfman W
    Climacteric; 2019 Oct; 22(5):507-510. PubMed ID: 31060386
    [No Abstract]   [Full Text] [Related]  

  • 2. Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women.
    Stubbs C; Mattingly L; Crawford SA; Wickersham EA; Brockhaus JL; McCarthy LH
    J Okla State Med Assoc; 2017 May; 110(5):272-274. PubMed ID: 28649145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
    Handley AP; Williams M
    J Am Assoc Nurse Pract; 2015 Jan; 27(1):54-61. PubMed ID: 24944075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Efficacy and Safety of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors in the Treatment of Menopausal Hot Flashes: A Systematic Review of Clinical Trials.
    Azizi M; Khani S; Kamali M; Elyasi F
    Iran J Med Sci; 2022 May; 47(3):173-193. PubMed ID: 35634530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SSRIs vs. SNRIs for Vasomotor Symptoms of Menopause.
    Newhouser LM; Maneval M; Rayalam K; Sabeeh G; Varela L
    Am Fam Physician; 2022 Apr; 105(4):430-431. PubMed ID: 35426647
    [No Abstract]   [Full Text] [Related]  

  • 6. Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor Use as a Predictor of a Diagnosis of Restless Legs Syndrome.
    Bailey AL; Makela EH; Asberg K
    J Psychiatr Pract; 2016 Jul; 22(4):263-9. PubMed ID: 27427838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Inquiry: Which nonhormonal treatments are effective for hot flashes?
    Kelsberg G; Maragh L; Safranek S
    J Fam Pract; 2016 May; 65(5):E1-3. PubMed ID: 27275942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.
    Pinkerton JV; Shifren JL; La Valleur J; Rosen A; Roesinger M; Siddhanti S
    Menopause; 2003; 10(1):45-52. PubMed ID: 12544676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom severity and quality of life in the management of vulvovaginal atrophy in postmenopausal women.
    Panay N; Palacios S; Bruyniks N; Particco M; Nappi RE;
    Maturitas; 2019 Jun; 124():55-61. PubMed ID: 31097180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to the patient with menopausal symptoms.
    Martin KA; Manson JE
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4567-75. PubMed ID: 19056840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal atrophy and sexual dysfunction in current users of systemic postmenopausal hormone therapy.
    Indhavivadhana S; Leerasiri P; Rattanachaiyanont M; Laiwejpithaya S; Tanmahasamut P; Techatraisak K; Angsuwathana S
    J Med Assoc Thai; 2010 Jun; 93(6):667-75. PubMed ID: 20572371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors affect vaginal proliferation and steroid hormone receptors.
    Kallak TK; Baumgart J; Göransson E; Nilsson K; Poromaa IS; Stavreus-Evers A
    Menopause; 2014 Apr; 21(4):383-90. PubMed ID: 24080848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Local estrogen therapy--clinical implications--2012 update].
    Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
    Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between selective serotonin and serotonin-noradrenaline reuptake inhibitor therapy and hematuria.
    Sarier M; Demir M; Emek M; Özgen A; Turgut H; Özdemir C
    Nord J Psychiatry; 2023 Jan; 77(1):31-35. PubMed ID: 35243962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SSRIs and SNRIs on Nocturnal Urinary Frequency.
    Medarov BI; Chaudhry H; Sun JH; Rane N; Judson MA
    Ann Pharmacother; 2016 Jun; 50(6):471-4. PubMed ID: 27005574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV.
    Trunfio M; Tang B; Iudicello JE; Ma Q; Franklin DR; Cookson D; Riggs PK; Cherner M; Moore DJ; Heaton RK; Letendre SL; Ellis RJ
    J Infect Dis; 2024 May; 229(5):1266-1276. PubMed ID: 38059529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute for Health and Care Excellence guideline on menopause.
    Sarri G; Pedder H; Dias S; Guo Y; Lumsden MA
    BJOG; 2017 Sep; 124(10):1514-1523. PubMed ID: 28276200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life and sexual function of naturally postmenopausal women on an ultralow-concentration estriol vaginal gel.
    Caruso S; Cianci S; Amore FF; Ventura B; Bambili E; Spadola S; Cianci A
    Menopause; 2016 Jan; 23(1):47-54. PubMed ID: 26079974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database.
    Benevent J; Araujo M; Karki S; Delarue-Hurault C; Waser J; Lacroix I; Tebeka S; Damase-Michel C
    J Clin Psychiatry; 2023 Jul; 84(4):. PubMed ID: 37437238
    [No Abstract]   [Full Text] [Related]  

  • 20. Adherence to Selective Serotonin and Serotonin-Norepinephrine Reuptake Inhibitor Prescriptions Affects Overall Medication Adherence in Older Persons: Evidence From the Italian Nationwide OsMed Health-DB Database.
    Marengoni A; Onder G; Degli Esposti L; Russo P; Sangiorgi D; Buda S; Fini M; Marchionni N; Bonassi S; Mammarella F; Marrocco W; Pozzi G; Palmer K; Monaco A; Pecorelli S; Pani L;
    J Clin Psychiatry; 2016 Dec; 77(12):1712-1718. PubMed ID: 28086009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.